Avara Management Ltd, Director, 10% Owner at Royalty Pharma plc (RPRX), sold 131,606 shares at $28.04 ($3.7M) on 2023-12-29, disclosed to the SEC on 2024-01-03.
Open-market sale of $3.7M RPRX by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.04 | 65,803 | $1.8M | 50.0% |
| 2 | $28.04 | 65,803 | $1.8M | 50.0% |
| Total | $28.04 avg | 131,606 | $3.7M | 100% |
| Filing → |
| RPRX | SELL | 2022-09-30 | $2.7M | — | Filing → |
| RPRX | SELL | 2022-09-26 | $17.4M | — | Filing → |
| RPRX | SELL | 2022-09-09 | $42.7M | — | Filing → |